Published: May 13, 2021, 03:08 IST | Updated: May 13, 2021, 03:08 IST
India's pandemic death toll has crossed 250,000. With the risk of the third wave growing, India has now approved Covaxin trials for children between 2 to 18 years of age. Palki Sharma tells you more.